Jam

Pure Energy Minerals appointed Cam Hosie, SLB’s New Energy SVP and former 8 Rivers CEO, to its board, enhancing expertise in decarbonization technologies and lithium extraction. Hosie’s leadership strengthens ties to SLB’s $3.2B R&D infrastructure, potentially accelerating Nevada brine projects under their 2019 partnership. His appointment aligns with rising lithium demand and SLB’s focus on modular direct lithium extraction (DLE) systems. While analysts highlight strategic advantages for tech commercialization and EV supply chains, challenges include leadership transition risks and market skepticism. The move follows Patrick Galletti’s departure, reflecting sector trends prioritizing operational expertise amid global lithium market shifts.

Battery X Metals (BATXF) is targeting aging EV batteries with its rebalancing technology, focusing on Nissan Leaf, the second-largest out-of-warranty EV cohort in the U.S. Partnering with Factor E Motors, the company’s Prototype 2.0 demonstrated 54% capacity restoration in NRC tests, aiming to undercut battery replacement costs by 60-70%. Targeting a $900M+ North American market by 2028, plans include expanding to Ford and Chevy models by 2026. The approach could reduce lithium demand by 18,000 tons annually, aligning with sustainability goals. CEO Massimo Bressi emphasizes adaptability as global EV sales hit 17.1 million units, positioning Battery X as a battery health leader amid rising replacement costs.

Deep Track Capital (14.82% DVAX shareholder) condemns ISS’s favorable review of Dynavax’s board ahead of its 2025 Annual Meeting, urging governance reforms and new directors. It cites ISS’s alleged dismissal of critical issues: Heplisav’s missed 2024 sales ($275M target) and market share decline (43% Q1 2025), lax capital allocation, and a staggered board structure. Dynavax’s 23% YTD stock drop and 40-point TSR lag vs. Nasdaq Biotech Index underscore concerns. Deep Track criticizes ISS for overlooking governance gaps and misrepresenting settlement talks, advocating for nominees with vaccine expertise to drive strategic shifts. The clash reflects broader activist pressure on biotech governance.

Sunnova Energy International Inc. is noncompliant with NYSE listing rules after delaying its Q1 2025 financial filing due to prolonged debt restructuring negotiations. The solar provider received an NYSE notice and has until November 19, 2025, to submit the overdue report, with possible delisting risks if unresolved. Resource prioritization toward debt discussions has hampered reporting processes, as flagged in prior SEC disclosures. Analysts note the delay may heighten investor concerns about liquidity in the residential solar sector amid rising rates and regulatory challenges. Shares continue trading under “NOVA” during the grace period.

California American Water unveiled its 2024 Consumer Confidence Reports, confirming compliance with EPA and California water quality standards. The reports detail drinking water sources, detected substances, and public health guidance, featuring updated visuals and simplified language to improve accessibility. President Kevin Tilden highlighted the consistent water excellence and educational value of the documents. Residents can access localized data via the company’s online portal using zip codes. As the largest U.S. public water utility, parent company American Water serves over 14 million people nationwide. Its California subsidiary provides water services to 700,000 residents, prioritizing tech innovation and operational transparency.

PG&E Corporation appointed utility industry veteran John O. Larsen to its Board of Directors following shareholder approval. Larsen, former CEO of Alliant Energy, brings 36 years of experience, including leadership in renewable energy expansion and grid modernization through initiatives like the Clean Energy Blueprint. His appointment reinforces PG&E’s focus on safety, infrastructure resilience, and customer-centric innovation as California accelerates decarbonization. Board Chair Kerry W. Cooper highlighted Larsen’s operational expertise and sustainable energy transition leadership. Larsen expressed commitment to advancing PG&E’s climate-resilient grid goals under CEO Patti Poppe. He will join PG&E’s Safety and Compensation committees, leveraging governance experience from roles at industry organizations. PG&E serves 16 million customers, prioritizing wildfire safety and grid upgrades.

Kroger, a leading U.S. grocery retailer, received Mental Health America’s 2025 Gold Bell Seal for its workplace mental health initiatives, a distinction awarded to only 40% of applicants. The company earned a perfect holistic wellness score through programs like subsidized counseling, stress management resources, flexible scheduling, and leadership training. As 76% of U.S. workers report moderate-to-high stress levels, Kroger’s focus on psychological safety addresses burnout and retention challenges. MHA’s rigorous audit recognized Kroger’s emphasis on crisis response, inclusion, and team-building. Analysts note this proactive approach strengthens competitiveness in the high-turnover retail sector, aligning employee well-being with business success.

Perimeter Medical Imaging AI partners with Intermountain Health to reduce cancer reoperation rates using advanced OCT imaging and AI. The collaboration, via a Development Support Agreement, will first analyze breast-conserving surgery outcomes to validate the clinical and economic impact of Perimeter’s FDA-cleared S-Series OCT and upcoming AI-driven B-Series device. Intermountain’s integrated healthcare-insurance model enables comprehensive assessment of reoperation costs and patient outcomes. CEO Adrian Mendes noted the data will inform FDA strategies and expansion into new surgical areas. A 2023 study estimated $1.2B annual U.S. costs for repeat breast cancer surgeries, which Perimeter’s real-time margin assessment aims to reduce.

NIO Inc. will convene its 2025 Annual General Meeting in Shanghai on June 25, allowing shareholders registered by May 23 to vote on strategic governance and growth initiatives. Key agenda items include proposals to advance next-gen autonomous driving technology and European market expansion, aligned with board-endorsed goals. The company also disclosed its 2024 Form 20-F, emphasizing R&D progress and battery-swapping infrastructure amid rising competition. Multi-listed shareholders (NYSE, HKEX, SGX) may participate through specified depositaries. The AGM underscores NIO’s focus on investor alignment and operational resilience as it navigates evolving EV industry challenges.

BioNxt Solutions has secured a pivotal European patent for its sublingual drug delivery platform, enhancing its intellectual property position for treating autoimmune diseases. The technology underpins BNT23001, a fast-dissolving oral film of Cladribine aimed at revolutionizing multiple sclerosis therapy by replacing injections with a needle-free, bioavailable alternative. Global patent filings are advancing in the U.S., Japan, and Eurasia, targeting a $150B+ autoimmune market. Upcoming bioequivalence studies in 2025 could enable accelerated EU approval. The platform also shows potential for lupus and arthritis treatments, with preclinical data suggesting improved delivery of biologic agents, positioning BioNxt as a leader in precision drug reformulation.